Can gene therapy halt diseases in babies before they’re even born?

Imagine a virus being slipped into a pregnant woman’s womb, delivering a corrective gene to a fetus and remedying a disease before the baby is even born.

Gene therapies — in which a corrective gene hitches a ride on a virus into a patient’s cells — are being tested as potential cures or treatments for sickle cell, Duchenne muscular dystrophy, and a range of other diseases. Some patients have already been treated with a gene therapy for an inherited form of blindness, the first to be approved in the U.S.

Now, imagine the virus-gene rig slipping into a pregnant woman’s womb, where it would reach the fetus and start remedying a disease before the baby is even born.

That kind of procedure remains an untested goal for now — one whose feasibility has been debated by scientists for years. But advances in fetal gene therapies in animal

You're reading a preview, sign up to read more.

More from STAT

STAT3 min readPsychology
Opinion: In A Medical Emergency, Who In Your Social Network Will Call For Help Quickest?
Applying the "strength of weak ties" theory to medicine, a weakly connected familiar in your social network can be the outside voice of reason who isn't afraid to call for…
STAT3 min readScience
Why Are Elite Athletes Different Than The Rest Of Us? Take A Look At Their Microbes
Elite athletes really are different from you and me. Or, at least their gut microbes are. Scientists who analyzed stool samples of 15 runners a week before and after they competed in the 2015 Boston Marathon found unusually high levels of one particu
STAT2 min read
AbbVie To Acquire Allergan For $63 Billion In Megamerger Of Pharma Giants
AbbVie said Tuesday it will acquire Allergan for $63 billion — the latest megamerger between two pharma giants seeking new ways to grow.